Abstract
This chapter describes methods utilized in establishing a mouse model of neuropsychiatric lupus encompassing both cognitive and emotional dysfunction, and a model of the influence of maternal antibody on the developing brain. The antibody of interest binds the N-methyl-d-aspartate receptor (NMDAR), a receptor for glutamate that is a major excitatory neurotransmitter in the brain involved in synaptic plasticity, in memory and learning, and in emotional responses.
We introduce basic concepts of these models and provide protocols for the following: (1) the induction of anti-dsDNA, anti-NMDAR antibodies, (2) testing serum antibody titer by ELISA, (3) breaching blood brain barrier (BBB) integrity with LPS and epinephrine, (4) passive transfer of pathology by injecting human and mouse brain-reactive antibodies into adult mouse as well as injecting the antibody into gestating mice and transfer of antibody from dam to fetus, (5) blocking NMDAR-mediated pathogenicity in vivo, (6) evacuation of blood from the brain by cardiac perfusion to preserve the brain for histology, (7) evaluating injured/apoptotic neurons in brain histology, (8) preparing membrane-enriched brain fractions for NMDAR analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alexander JJ, Quigg RJ (2007) Systemic lupus erythematosus and the brain: what mice are telling us. Neurochem Int 50:5–11
Banks WA (2010) Mouse models of neurological disorders: a view from the blood–brain barrier. Biochim Biophys Acta 1802:881–888
Denburg SD, Larocque L, Denburg JA (1999) Cognitive dysfunction in systemic lupus erythematosus. In: Systemic Lupus Erythematosus, Fourth Edition, Lahita RG (ed.). Academic Press, San Diego, pp 611–629
Hanly JG (2007) New insights into central nervous system lupus: a clinical perspective. Curr Rheumatol Rep 9:116–124
Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B (2006) Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA 103:678–683
Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, Volpe BT (2004) Cognition and immunity; antibody impairs memory. Immunity 21:179–188
Gaynor B, Putterman C, Valadon P, Spatz L, Scharff MD, Diamond B (1997) Peptide inhibition of glomerular deposition of an anti-DNA antibody. Proc Natl Acad Sci USA 94:1955–1960
Putterman C, Diamond B (1998) Immunization with a peptide surrogate for double-stranded DNA (dsDNA) induces autoantibody production and renal immunoglobulin deposition. J Exp Med 188:29–38
Hawkins BT, Davis TP (2005) The blood–brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–185
Paolinelli R, Corada M, Orsenigo F, Dejana E (2011) The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? Pharmacol Res 63:165–171
Daneman R, Zhou L, Kebede AA, Barres BA (2010) Pericytes are required for blood–brain barrier integrity during embryogenesis. Nature 468:562–566
Banks WA, Erickson MA (2010) The blood–brain barrier and immune function and dysfunction. Neurobiol Dis 37:26–32
Kowal C, Degiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, Diamond B (2006) Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci USA 103:19854–19859
Lahita RG (1988) Systemic lupus erythematosus: learning disability in the male offspring of female patients and relationship to laterality. Psychoneuroendocrinology 13:385–396
McAllister DL, Kaplan BJ, Edworthy SM, Martin L, Crawford SG, Ramsey-Goldman R, Manzi S, Fries JF, Sibley J (1997) The influence of systemic lupus erythematosus on fetal development: cognitive, behavioral, and health trends. J Int Neuropsychol Soc 3:370–376
Neri F, Chimini L, Bonomi F, Filippini E, Motta M, Faden D, Lojacono A, Rebaioli CB, Frassi M, Danieli E, Tincani A (2004) Neuropsychological development of children born to patients with systemic lupus erythematosus. Lupus 13:805–811
Ross G, Sammaritano L, Nass R, Lockshin M (2003) Effects of mothers’ autoimmune disease during pregnancy on learning disabilities and hand preference in their children. Arch Pediatr Adolesc Med 157:397–402
Tincani A, Danieli E, Nuzzo M, Scarsil M, Motta M, Cimaz R, Lojacono A, Nacinovich R, Taddei F, Doria A, Brucato A, Meroni P (2006) Impact of in utero environment on the offspring of lupus patients. Lupus 15:801–807
Lee JY, Huerta PT, Zhang J, Kowal C, Bertini E, Volpe BT, Diamond B (2009) Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 15:91–96
Arinuma Y, Yanagida T, Hirohata S (2008) Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 58:1130–1135
Fragoso-Loyo H, Cabiedes J, Orozco-Narvaez A, Davila-Maldonado L, Atisha-Fregoso Y, Diamond B, Llorente L, Sanchez-Guerrero J (2008) Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis. PLoS One 3:e3347
Yoshio T, Onda K, Nara H, Minota S (2006) Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 54:675–678
Banks WA (2001) Enhanced leptin transport across the blood-brain barrier by alpha 1-adrenergic agents. Brain Res 899:209–217
Xaio H, Banks WA, Niehoff ML, Morley JE (2001) Effect of LPS on the permeability of the blood–brain barrier to insulin. Brain Res 896:36–42
DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B (2001) A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189–1193
Diamond B, Bloom O, Al Abed Y, Kowal C, Huerta PT, Volpe BT (2011) Moving towards a cure: blocking pathogenic antibodies in systemic lupus erythematosus. J Intern Med 269:36–44
Owens GP, Burgoon MP, Devlin ME, Gilden DH (1997) Extraction and purification of active IgG from SSPE and MS brain. J Virol Methods 68:119–125
Fernandes AM, Maurer-Morelli CV, Campos CB, Mello ML, Castilho RF, Langone F (2004) Fluoro-Jade, but not Fluoro-Jade B, stains non-degenerating cells in brain and retina of embryonic and neonatal rats. Brain Res 1029:24–33
Schmued LC, Albertson C, Slikker W Jr (1997) Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Res 751:37–46
Ogawa Y, Kanoh S (1984) Enhancement of endotoxicity and reactivity with carbocyanine dye by sonication of lipopolysaccharide. Microbiol Immunol 28:1313–1323
Gao B, Wang Y, Tsan MF (2006) The heat sensitivity of cytokine-inducing effect of lipopolysaccharide. J Leukoc Biol 80:359–366
Nagano I, Takao T, Nanamiya W, Takemura T, Nishiyama M, Asaba K, Makino S, De Souza EB, Hashimoto K (1999) Differential effects of one and repeated endotoxin treatment on pituitary–adrenocortical hormones in the mouse: role of interleukin-1 and tumor necrosis factor-alpha. Neuroimmunomodulation 6:284–292
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media New York
About this protocol
Cite this protocol
Kowal, C., Diamond, B. (2012). Aspects of CNS Lupus: Mouse Models of Anti-NMDA Receptor Antibody Mediated Reactivity. In: Perl, A. (eds) Autoimmunity. Methods in Molecular Biology, vol 900. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-720-4_9
Download citation
DOI: https://doi.org/10.1007/978-1-60761-720-4_9
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-719-8
Online ISBN: 978-1-60761-720-4
eBook Packages: Springer Protocols